Evluation of Thyroid Functions in Hemodialysis Childern in Sohag University Hospital

NCT05451472 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 39

Last updated 2022-07-11

No results posted yet for this study

Summary

Thyroid gland and its hormones play an important role in organ development and the homeostatic control of many physiological mechanisms such as body growth and energy expenditure. The two main thyroid hormones are triiodothyronine (T3) and thyroxine (T4) affect renal development and metabolism so any impairment in thyroid functions lead to or aggravate kidney diseases.

On the other hand, kidneys play an important role in the thyroid metabolism as it normally contributes to the clearance of iodide, primarily by glomerular filtration. Among patients with renal failure, there is diminished iodide excretion and an increase in plasma inorganic iodide, which results in increased uptake of the iodide by the thyroid gland. Increases in total body inorganic iodide can potentially block thyroid hormone production (the Wolff-Chaik off effect). Such a change may explain the slightly higher frequency of goiter and hypothyroidism in patients with chronic kidney diseases.

The kidneys affect the hypothalamic pituitary-thyroid axis, so any impairment in kidney functions leads to disturbed thyroid physiology. All levels of the hypothalamic-pituitary-thyroid axis may be involved, including alterations in hormone production, distribution, and excretion.

End stage renal disease (ESRD) and hemodialysis (HD) affect the levels of all thyroid hormones. The earliest and the most common thyroid function abnormality in patients with ESRD on HD is low T3 level (especially total T3 than free T3). This is called 'low T3 syndrome. The prevalence of subclinical hypothyroidism has been reported to be much higher in patients with ESRD on HD than in the general population.

Due to similarity of signs and symptoms, sometimes it is difficult to identify subjects with ESRD also has hypothyroidism; therefore, different studies have been carried out to establish the incidence of these conditions.

Conditions

  • Chronic Renal Failure

Interventions

DIAGNOSTIC_TEST

thyroid function tests

Thyroid function tests:thyroid stimulating hormone (TSH), total thyroxine (T4), free thyroxine (FT4), total triiodothyronine (T3), and free triiodothyronine (FT3)

DIAGNOSTIC_TEST

complete blood count

complete blood count

DIAGNOSTIC_TEST

serum creatinine

serum creatinine

DIAGNOSTIC_TEST

blood urea

blood urea

DIAGNOSTIC_TEST

serum electrolyte

serum electrolyte

DIAGNOSTIC_TEST

serum calcium

serum calcium

DIAGNOSTIC_TEST

serum phosphorus

serum phosphorus

DIAGNOSTIC_TEST

parathyroid hormone level

parathyroid hormone level

DIAGNOSTIC_TEST

liver function test

ALT\_AST\_Total biliruin\_total protein \_serum albumin

DIAGNOSTIC_TEST

arterial blood gases

PH\_PCO2\_PO2\_HCO3\_base deficit

DIAGNOSTIC_TEST

complete urine analysis

complete urine analysis

Sponsors & Collaborators

  • Sohag University

    lead OTHER

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
2 Years
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-01
Primary Completion
2023-01-01
Completion
2023-01-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05451472 on ClinicalTrials.gov